Stravoravdi P, Natsis K, Kirtsis P, Retalis G, Konstandinidis E, Polyzonis M
Theagenion Cancer Institute, Thessaloniki, Greece.
Eur Urol. 1996;29(4):477-82. doi: 10.1159/000473800.
Seventeen patients with transitional cell carcinoma of the urinary bladder were studied. Twelve patients did not have a recurrence 2 years after a transurethral resection (TUR) followed by interferon (IFN)-alpha 2b treatment. This observation led us to study the ultrastructural morphology of the noninvolved urothelium in 8 of the above 12 patients.
All patients had a primary solitary grade I or II tumor. Topical therapy was started after TUR. Each patient received a total of 22 instillations of 50 MU IFN-alpha 2b in 12 months according to the standard procedure. After the first year, a repetitive dose of 50 MU IFN-alpha 2b was administered every 2 months for a period of 1 more year.
At the end of therapy, certain ultrastructural modifications were observed indicating a partial restoration of the urothelium: the existence of asymmetric unit membrane, a well-developed Golgi apparatus and an increase of the filaments. The cells were joined to each other with well-developed tight junctions. Tubuloreticular inclusions were also observed.
Prevention of recurrence by restoring the morphology of the noninvolved urothelium in response to IFN treatment deserves further examination.
对17例膀胱移行细胞癌患者进行了研究。12例患者经尿道切除术(TUR)联合α-2b干扰素治疗后2年未复发。这一观察结果促使我们对上述12例患者中的8例未受累尿路上皮的超微结构形态进行研究。
所有患者均为原发性单发I级或II级肿瘤。TUR术后开始局部治疗。根据标准程序,每位患者在12个月内共接受22次50 MU α-2b干扰素灌注。第一年结束后,每2个月重复给予50 MU α-2b干扰素,持续1年。
治疗结束时,观察到一些超微结构改变,表明尿路上皮有部分恢复:存在不对称单位膜、发育良好的高尔基体以及细丝增加。细胞通过发育良好的紧密连接相互连接。还观察到管状网状包涵体。
通过恢复未受累尿路上皮形态以应对干扰素治疗来预防复发值得进一步研究。